Acadian Asset Management LLC Veracyte, Inc. Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$19.49 - $28.11 $2.81 Million - $4.05 Million	-144,235 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$16.13 - $30.17 $1.83 Million - $3.43 Million	-113,676 Reduced 44.08%	144,235 $3.51 Million
Q4 2019 Feb 06, 2020	SELL	$20.78 - $29.99 $927,660 - $1.34 Million	-44,642 Reduced 14.76%	257,911 $7.2 Million
Q3 2019 Nov 07, 2019	SELL	$23.87 - $30.93 $2.14 Million - $2.77 Million	-89,695 Reduced 22.87%	302,553 $7.26 Million
Q2 2019 Aug 08, 2019	BUY	$22.1 - $28.56 $841,015 - $1.09 Million	38,055 Added 10.74%	392,248 $11.2 Million

Q1 2019 May 09, 2019	BUY	$12.0 - $25.76 $491,616 - $1.06 Million	40,968 Added 13.08%	354,193 $8.86 Million
Q4 2018 Feb 07, 2019	BUY	$9.15 - $14.85 $625,292 - $1.01 Million	68,338 Added 27.91%	313,225 $3.94 Million
Q3 2018 Oct 30, 2018	BUY	$9.55 - $12.64 $1.94 Million - $2.57 Million	203,037 Added 485.15%	244,887 $2.34 Million
Q2 2018 Jul 24, 2018	BUY	$5.39 - $9.66 $225,571 - $404,271	41,850 New	41,850 $391,000

254

81.2M

43K

82K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.7B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.